Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is a...
Q1 2026
May 14, 2026
FY 2025
Dec 31, 2025
Q4 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025